While Moderna is focused on future and current opportunities, the president and CEO, Stéphane Bancel, has left no doubt about whether he sees things through a glass half-full or half-empty perspective when it comes to the emergence of the new omicron coronavirus variant.
He said in the Financial Times that there is no scenario where today’s vaccines are as efficient against the delta variant as they have been against all previous forms. Furthermore, he predicted that the decline may be substantial.